Farther Finance Advisors’s Terns Pharmaceuticals TERN Stock Holding History

Farther Finance Advisors’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-62	Closed	-$3.27K	–	6106
2026 Q1	$3.27K	Buy	62 +60	+3,000%	+$2.46K	﹤0.01%	4699
2025 Q4	$81	Buy	+2	New	+$46	﹤0.01%	5317
2025 Q1	–	Sell	-27	Closed	-$150	–	4419
2024 Q4	$150	Hold	27	–	–	﹤0.01%	3716
2024 Q3	$225	Hold	27	–	–	﹤0.01%	3631
2024 Q2	$185	Sell	27 -1	-4%	-$6	﹤0.01%	3509
2024 Q1	$199	Buy	28 +8	+40%	+$52	﹤0.01%	3277
2023 Q4	$130	Buy	+20	New	+$106	﹤0.01%	3283

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Farther Finance Advisors's TERN Position: Q2 2026 in Review

Farther Finance Advisors sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 62 shares — an estimated $3.27K sold.

Farther Finance Advisors first reported a position in TERN in Q4 2023 and held it in 7 quarters. The position peaked at $3.27K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Farther Finance Advisors reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Farther Finance Advisors sold 62 Terns Pharmaceuticals shares in Q2 2026, an estimated $3.27K.
Farther Finance Advisors first reported a position in Terns Pharmaceuticals in Q4 2023 and held it in 7 quarters.
Farther Finance Advisors's Terns Pharmaceuticals position peaked at $3.27K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.